PROFProfound Medical Corp
PROF
Profound Medical Corp407
Mkt Cap
$253.27MVolume
24,168.0052W High
$8.9552W Low
$3.76PE Ratio
-5.59PROF Fundamentals
Price
$6.84Prev Close
$6.97Open
$6.9550D MA
$6.46Beta
0.96Avg. Volume
90,906.04EPS (Annual)
-$1.41P/B
4.26Rev/Employee
$99,370.37$182.53
Wall Street Analysts See a 59.68% Upside in Profound Medical (PROF): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 59.7% in Profound Medical (PROF). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Profound Medical (PROF) Reports Q1 Loss, Tops Revenue Estimates
Profound Medical (PROF) delivered earnings and revenue surprises of +21.91% and +4.79%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Indivior Pharmaceuticals Inc. (INDV) Q1 Earnings and Revenues Beat Estimates
Indivior Pharmaceuticals Inc. (INDV) delivered earnings and revenue surprises of +50.78% and +18.01%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Profound Medical (PROF) Projected to Post Earnings on Thursday
Profound Medical (NASDAQ:PROF) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-profound-medical-corp-stock...
Why Medtech Giants Are Quietly Paying Up for AI Diagnostics
Why Medtech Giants Are Quietly Paying Up for AI Diagnostics Why Medtech Giants Are Quietly Paying Up for AI Diagnostics PR Newswire VANCOUVER, BC, April 29, 2026 ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD.VANCOUVER, BC, April 29, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary There's a...
Profound Medical (TSE:PRN) Trading Down 2.9% - Should You Sell?
Profound Medical (TSE:PRN) Trading Down 2.9% - Here's What Happened...
Profound Medical Showcases TULSA Data, AI Software Upgrades, and Reimbursement Tailwinds at Conference
Profound Medical (NASDAQ:PROF) highlighted what it described as growing clinical evidence, expanding software capabilities, and improving reimbursement dynamics for its MRI-guided "incision-free" ultrasound platform during a conference presentation led by Arun, a company executive who said he has be...
Profound Medical (NASDAQ:PROF) Shares Down 4.3% - Time to Sell?
Profound Medical (NASDAQ:PROF) Stock Price Down 4.3% - What's Next...
Profound Medical (TSE:PRN) Director Dr. Arun Menawat Purchases 20,000 Shares
Profound Medical Corp. (TSE:PRN - Get Free Report) Director Dr. Arun Menawat purchased 20,000 shares of the stock in a transaction that occurred on Friday, March 20th. The stock was acquired at an average cost of C$6.96 per share, with a total value of C$139,200.00. Following the completion of the...
Insider Buying: Profound Medical (TSE:PRN) Director Acquires 20,000 Shares of Stock
Profound Medical Corp. (TSE:PRN - Get Free Report) Director Dr. Arun Menawat bought 20,000 shares of the stock in a transaction on Friday, March 20th. The shares were acquired at an average cost of...
<
1
2
...
>
Compact View
Not available
Not available